MAD2L2 is involved in mitosis checkpoint control; its expression is upregulated in colon cancer tissue as compared with the adjacent normal tissue, and there is excessive MAD2L2 expression in patients with colorectal cancer with poor prognosis [31]. Here, MAD2L2 is linked to colorectal cancer.